日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity

新型N-1取代的氟喹诺酮类药物可抑制人拓扑异构酶I活性并表现出抗增殖活性。

Oppegard, Lisa M; Delgado, Justine L; Kulkarni, Chaitanya A; Towle, Tyrell R; Hart, Delaney E; Williams, Bridget P; Lentz, Sarah R C; Norris, Beverly J; Flory, Craig M; Schumacher, Robert J; Murry, Daryl J; Kerns, Robert J; Hiasa, Hiroshi

The C7-aminomethylpyrrolidine group rescues the activity of a thio-fluoroquinolone

C7-氨甲基吡咯烷基团可恢复硫代氟喹诺酮的活性

Lentz, Sarah R C; Chheda, Pratik R; Oppegard, Lisa M; Towle, Tyrell R; Kerns, Robert J; Hiasa, Hiroshi

Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase

新型N-1氟喹诺酮衍生物的设计、合成和评价:探究其与DNA促旋酶活性位点酪氨酸的结合接触

Towle, Tyrell R; Kulkarni, Chaitanya A; Oppegard, Lisa M; Williams, Bridget P; Picha, Taylor A; Hiasa, Hiroshi; Kerns, Robert J

Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site

氟喹诺酮类药物通过促进 Mg(2+) 与第二个金属结合位点的结合来刺激拓扑异构酶 IV 的 DNA 裂解活性

Lisa M Oppegard, Heidi A Schwanz, Tyrell R Towle, Robert J Kerns, Hiroshi Hiasa

Bypassing fluoroquinolone resistance with quinazolinediones: studies of drug-gyrase-DNA complexes having implications for drug design

利用喹唑啉二酮类药物绕过氟喹诺酮耐药性:药物-DNA促旋酶-DNA复合物的研究及其对药物设计的影响

Drlica, Karl; Mustaev, Arkady; Towle, Tyrell R; Luan, Gan; Kerns, Robert J; Berger, James M